BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free, the Pittsburgh Post-Gazette reports. Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.
1. FTC refunds customers for fraudulent health plans sold by Benefytt
2. Health systems consider dropping Medicare Advantage plans due to financial losses
3. UnitedHealth faces rising lawsuits following Change Healthcare cyberattack
4. MedPAC calls for 'major overhaul' of Medicare Advantage policies
5. Medicare to cover Novo Nordisk's weight-loss drug for heart patients
6. AT&T faces second lawsuit over $8 billion pension risk transfer